Reprogramming of cells to a new fate
First Claim
Patent Images
1. A method of converting an animal cell from a first non-pluripotent cell fate to a second non-pluripotent cell fate, the method comprising:
- (a) introducing a polynucleotide encoding an Oct4 polypeptide, and optionally one or more reprogramming factors comprising polynucleotides encoding a Klf4 polypeptide, a Sox2 polypeptide, or a c-Myc polypeptide, into a first non-pluripotent cell, or contacting a first non-pluripotent cell with an Oct4 polypeptide, and optionally one or more reprogramming factors comprising a Klf4 polypeptide, a Sox2 polypeptide, or a c-Myc polypeptide,(b) limiting the expression of endogenous Nanog in the cells from step (a) to a level substantially lower than the level of expression of endogenous Nanog in an induced pluripotent cell (iPSC), thereby generating a non-pluripotent intermediate cell and(c) inducing differentiation of the cell under conditions to generate a cell having a second non-pluripotent cell fate,wherein the first non-pluripotent cell is a mesodermal, ectodermal or endodermal cell, and wherein the cell having the second non-pluripotent cell fate from step (c) is in the same or different cell lineage as the first non-pluripotent cell.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention generally provides methods and compositions for transdifferentiation of an animal cell from a first non-pluripotent cell fate to a second non-pluripotent cell fate. Also provided are methods and compositions for the transdifferentiation of an animal cell from a non-pluripotent mesodermal, endodermal, or ectodermal cell fate to a different non-pluripotent mesodermal, endodermal, or ectodermal cell fate.
-
Citations
5 Claims
-
1. A method of converting an animal cell from a first non-pluripotent cell fate to a second non-pluripotent cell fate, the method comprising:
-
(a) introducing a polynucleotide encoding an Oct4 polypeptide, and optionally one or more reprogramming factors comprising polynucleotides encoding a Klf4 polypeptide, a Sox2 polypeptide, or a c-Myc polypeptide, into a first non-pluripotent cell, or contacting a first non-pluripotent cell with an Oct4 polypeptide, and optionally one or more reprogramming factors comprising a Klf4 polypeptide, a Sox2 polypeptide, or a c-Myc polypeptide, (b) limiting the expression of endogenous Nanog in the cells from step (a) to a level substantially lower than the level of expression of endogenous Nanog in an induced pluripotent cell (iPSC), thereby generating a non-pluripotent intermediate cell and (c) inducing differentiation of the cell under conditions to generate a cell having a second non-pluripotent cell fate, wherein the first non-pluripotent cell is a mesodermal, ectodermal or endodermal cell, and wherein the cell having the second non-pluripotent cell fate from step (c) is in the same or different cell lineage as the first non-pluripotent cell. - View Dependent Claims (2, 3, 4, 5)
-
Specification